Related Experiment Video
Updated: Jun 23, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme
1Program in Biomedical Sciences, Program in Biological Sciences, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Abstract:
Many B cell cancers are characterized in part by the dysregulation of the NF-kappaB signaling pathway. A new study identifies somatic mutations in TNFAIP3, the gene encoding the NF-kappaB inhibitor A20, in Hodgkin lymphomas and primary mediastinal lymphomas. These data reveal the role of A20 as a tumor suppressor protein.
Insights
Researchers discovered mutations in the TNFAIP3 gene, which produces the NF-kappaB inhibitor A20, in specific B cell cancers. This finding highlights A20
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- B cell cancers often involve abnormal NF-kappaB signaling.
- The NF-kappaB pathway regulates immune responses and cell survival.
Purpose of the Study:
- To investigate the role of TNFAIP3 mutations in B cell lymphomas.
- To identify potential tumor suppressor functions related to NF-kappaB inhibition.
Main Methods:
- Somatic mutation analysis of the TNFAIP3 gene.
- Analysis of patient samples from Hodgkin lymphomas and primary mediastinal lymphomas.
Main Results:
- Somatic mutations in TNFAIP3 were identified in Hodgkin lymphomas and primary mediastinal lymphomas.
- These mutations affect the expression or function of the A20 protein.
Conclusions:
- The TNFAIP3 gene, encoding A20, is somatically mutated in specific B cell lymphomas.
- A20 functions as a tumor suppressor protein, and its dysregulation contributes to lymphomagenesis.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

